Loading…
Avalo Therapeutics, Inc. is projected to rise to $24.82 by 2027, a +57% move from its current price of $15.79. AVTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $15.08 | $15.80 | $16.56 | +0.05% |
| May 30 | $14.79 | $15.81 | $16.89 | +0.11% |
| May 31 | $14.58 | $15.82 | $17.15 | +0.16% |
| Jun 1 | $14.41 | $15.82 | $17.38 | +0.22% |
| Jun 2 | $14.26 | $15.83 | $17.58 | +0.27% |
| Jun 3 | $14.12 | $15.84 | $17.77 | +0.33% |
| Jun 4 | $14.00 | $15.85 | $17.94 | +0.38% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.00 | $15.85 | $17.94 | +0.38% |
| Week 2 | $13.35 | $15.91 | $18.96 | +0.76% |
| Week 3 | $12.89 | $15.97 | $19.79 | +1.14% |
| Week 4 | $12.51 | $16.03 | $20.54 | +1.53% |
| Week 5 | $12.20 | $16.09 | $21.23 | +1.91% |
| Week 6 | $11.93 | $16.15 | $21.88 | +2.30% |
| Week 7 | $11.68 | $16.21 | $22.50 | +2.69% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Avalo Therapeutics, Inc. is a clinical-stage biotechnology company that develops IL-1ß based treatments for immune mediated inflammatory diseases in the United States. Its lead product AVTX-009 is a humanized monoclonal antibody that binds to interleukin-1ß and is in phase 2 clinical trial to treat inflammatory diseases.
The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.
AVTX is a healthcare stock with a current price of $16.35. It has a market cap of $859.45M and is ranked 2641 by market capitalization.
The forecast outlook shows a path of rising prices with a neutral stance in 2026 and bullish sentiment from 2027 onward. The year by year averages indicate growth: 2027 avg $25.61, 2028 avg $32.59, 2029 avg $33.41, 2030 avg $35.31, 2033 avg $45.07, 2034 avg $51.47, 2035 avg $56.23, 2040 avg $69.87, and 2050 avg $145.13. The forecast also notes a strong bullish trend across the long horizon.
A major floor 54.6% below — a decisive break under it would weaken the trend.
The nearest floor, 18.6% below — buyers have tended to step in here.
The nearest ceiling, 44.8% above — a clean break opens room to run.
A major ceiling 72.2% above — clearing it would confirm fresh momentum.
Key AVTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AVTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $16.21 | Sell | $16.26 | Sell |
| MA 10 | $17.01 | Sell | $16.76 | Sell |
| MA 20 | $17.34 | Sell | $16.82 | Sell |
| MA 50 | $15.60 | Buy | $16.28 | Sell |
| MA 100 | $15.78 | Buy | $15.83 | Sell |
| MA 200 | $15.16 | Buy | $15.28 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.30 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -42.63 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.41 | Sell |
| ROC (12) | -26.80 | Sell |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.61 | Buy |
| Awesome (5,34) | 0.22 | Buy |
| Ultimate (7,14,28) | 21.22 | Buy |
| Momentum (10) | -4.15 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 15.87 | Sell |
| ADX (14) | 14.38 | Neutral |
| ATR (14) | 0.71 | Info |
30 day technical picture shows a neutral stance with RSI14 at 50. The 50 day simple moving average sits at $15.60 and the 200 day simple moving average at $15.09. Immediate support is at $12.86 and resistance at $22.87. The 30 day price range spans from $11.80 to $22.66.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $12.86 | $15.79 | $24.78 | 0% | Neutral | |
| $18.32 | $24.82 | $36.28 | +57% | Bullish | |
| $22.10 | $31.49 | $48.63 | +99% | Bullish | |
| $21.62 | $32.17 | $51.87 | +104% | Bullish | |
| $22.46 | $34.76 | $58.11 | +120% | Bullish | |
| $20.55 | $32.98 | $56.87 | +109% | Bullish | |
| $19.61 | $32.58 | $57.77 | +106% | Bullish | |
| $26.36 | $45.26 | $82.27 | +187% | Bullish | |
| $29.26 | $51.89 | $96.49 | +229% | Bullish | |
| $30.56 | $55.90 | $106.15 | +254% | Bullish | |
| $33.98 | $72.12 | $149.41 | +357% | Bullish | |
| $66.60 | $148.00 | $340.41 | +837% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $12.86 | $15.79 | $18.83 | +0.00% |
| June 2026 | $14.10 | $16.82 | $20.74 | +6.55% |
| July 2026 | $13.70 | $16.59 | $20.91 | -1.40% |
| August 2026 | $13.53 | $16.57 | $21.25 | -0.09% |
| September 2026 | $14.55 | $17.99 | $23.39 | +8.54% |
| October 2026 | $15.02 | $18.73 | $24.66 | +4.14% |
| November 2026 | $14.39 | $18.09 | $24.07 | -3.45% |
| December 2026 | $14.55 | $18.43 | $24.78 | +1.92% |
Click any year to see its month-by-month AVTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AVTX to range from $12.86 to $24.78 through 2026. The $15.79 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The AVTX price prediction for 2027 points to an average of $24.82 (low $18.32, high $36.28) — a potential gain of +57% on today's $15.79. Buyers look set to stay in control over this stretch.
In 2028, AVTX is projected to trade between $22.10 and $48.63, averaging $31.49 — a potential gain of +99% from today's $15.79. That is up +27% on the projected 2027 average. Momentum favours further upside here.
Avalo Therapeutics, Inc.'s 2029 outlook centres on $32.17, within a $21.62 to $51.87 range. That is up +2% on the projected 2028 average. That marks a +104% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, AVTX could reach as high as $58.11, with a base case around $34.76 and support toward $22.46 — roughly +120% from $15.79. Momentum favours further upside here.
Expect AVTX to range from $20.55 to $56.87 through 2031. The $32.98 average target implies a +109% move from current prices. That is -5% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The AVTX price prediction for 2032 points to an average of $32.58 (low $19.61, high $57.77) — a potential gain of +106% on today's $15.79. Momentum favours further upside here.
In 2033, AVTX is projected to trade between $26.36 and $82.27, averaging $45.26 — a potential gain of +187% from today's $15.79. That is up +39% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Avalo Therapeutics, Inc.'s 2034 outlook centres on $51.89, within a $29.26 to $96.49 range. That is up +15% on the projected 2033 average. That marks a +229% change versus current levels. Momentum favours further upside here.
By 2035, AVTX could reach as high as $106.15, with a base case around $55.90 and support toward $30.56 — roughly +254% from $15.79. Buyers look set to stay in control over this stretch.
Expect AVTX to range from $33.98 to $149.41 through 2040. The $72.12 average target implies a +357% move from current prices. That is up +29% on the projected 2035 average. Momentum favours further upside here.
The AVTX price prediction for 2050 points to an average of $148.00 (low $66.60, high $340.41) — a potential gain of +837% on today's $15.79. Buyers look set to stay in control over this stretch.
Investing $1,000 in AVTX today (≈ 63.331222 AVTX) could be worth
$9,373.19
+$8,373.19 (+837%) by 2050 · US Dollar
Based on the average projected AVTX price of $148 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AVTXwould be worth at today's price.
$1,000 invested in AVTX on May 27, 2025 (≈ 276.243103 AVTX) would be worth
$4,361.88
+$3,361.88 (+336.2%) today · 4.36× · US Dollar
Based on a AVTX entry price of $3.62 vs. today's $15.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $16.29 | $969.31 | -3.1% |
| 1 month ago | $14.42 | $1,095.01 | +9.5% |
| 3 months ago | $17.64 | $895.12 | -10.5% |
| 6 months ago | $19 | $831.05 | -16.9% |
| 1 year ago | $3.62 | $4,361.88 | +336.2% |
| All time (5.0y) ago | $8,006.4 | $1.97 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AVTX forecast.
Our base-case forecast reaches $32.00 around 2029.
Implied market cap at $32.00: $1.68B
The multi year forecast depicts bullish sentiment from 2027 onward, with rising average prices and meaningful upside. By 2030, the forecasted average price is $35.31 with an estimated ROI of 116%. The 2040 forecast shows an average of $69.87 with a projected ROI of 327.4%.
By 2050 the average is $145.13 and the forecasted ROI is 787.6%. Earlier years like 2027–2029 show continued upside with 2027 avg $25.61, 2028 avg $32.59, and 2029 avg $33.41, all designated bullish. These are estimates, not guarantees, and are subject to market and clinical development risks.
Tap a question to reveal the answer.
The 2030 forecasted average price is $35.31 with an ROI of 116%. The forecast range for 2030 is min $22.35, max $60.08.
Yes. The forecast maximum for 2030 is $60.08, while the 2030 average is $35.31 and the 2030 minimum is $22.35.
The forecast indicates bullish sentiment from 2027 onward with rising averages and sizable ROIs, including 2027 avg $25.61, 2040 avg $69.87 ROI 327.4, and 2050 avg $145.13 ROI 787.6. These are estimates, not guarantees.
The momentum is neutral with RSI14 at 50. The SMA50 is $15.60 and the SMA200 is $15.09. Short-term support sits at $12.86 and resistance at $22.87; the 30-day range is $11.80 to $22.66.
For 2050 the forecasted average price is $145.13 with a max of $333.80 and a min of $65.31, and an ROI of 787.6% marked as bullish.
Avalo Therapeutics, Inc. Community Discussion
0Share your Avalo Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.